Loading clinical trials...
Loading clinical trials...
A Phase II Randomized Trial Evaluating the Addition of High or Standard Intensity Radiation to Gemcitabine and Nab-paclitaxel for Locally Advanced Pancreatic Cancer
Conditions
Interventions
low intensity radiation therapy
Capecitabine
+3 more
Locations
46
United States
Kaiser Permanente Oakland-Broadway
Oakland, California, United States
Kaiser Permanente Medical Center - Santa Clara
Santa Clara, California, United States
Kaiser Permanente Cancer Treatment Center
South San Francisco, California, United States
Emory University/Winship Cancer Institute
Atlanta, Georgia, United States
Saint Joseph Hospital
Chicago, Illinois, United States
Decatur Memorial Hospital
Decatur, Illinois, United States
Start Date
August 1, 2013
Primary Completion Date
June 1, 2016
Completion Date
June 1, 2016
Last Updated
July 13, 2018
NCT06423326
NCT04389632
NCT04895709
NCT05053971
NCT05825066
NCT04550494
Lead Sponsor
Radiation Therapy Oncology Group
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions